SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of Quest Diagnostics

367

Quest Diagnostics

DGX

The diagnostics testing company’s services range from routine blood work to gene-based testing.

Looking for leads, investment insights, or competitive intelligence?

CEO

Stephen H. Rusckowski

CEO Title

Chairman, President & Chief Executive Officer

Sector

Health Care

Industry

Health Care: Pharmacy and Other Services

HQ Location

Secaucus, N.J.

Years on Fortune 500 List

18

Employees

45,000

Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$7,7092.6%
Profits ($M)$772.019.7%
Assets ($M)$10,503
Total Stockholder Equity ($M)$4,921
Market Value — as of March 29, 2018 ($M)$13,619
Profit Ratios
Profit as % of Revenues10.0%
Profits as % of Assets7.4%
Profits as % of Stockholder Equity15.7%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)5.50
EPS % Change (from 2016)22.0%
EPS % Change (5 year annual rate)9.7%
EPS % Change (10 year annual rate)12.2%
Total Return
Total Return to Investors (2017)9.2%
Total Return to Investors (5 year, annualized)13.4%
Total Return to Investors (10 year, annualized)8.0%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Quest Diagnostics

How Theranos Misled Me

And how I screwed up, too.

Read More →
Disruptive diagnostics firm Theranos gets boost from FDA

The agency clears the company's test platform and herpes test—a possible prelude to other approvals.

Read More →